Associated Papers
Modeling the novel SERD elacestrant in cultured fulvestrant-refractory HR-positive breast circulating tumor cells.
Dubash TD et al.
Breast Cancer Research and Treatment, 2023
37318638 (PubMed )
Supplement: 10549_2023_6998_MOESM1_ESM.pdf
Select a paper to view details